Prevention of hyperacute rejection by phosphatidylinositol-anchored mini-complement receptor type 1

By Mikata S.   Miyagawa S.   Yoshitatsu M.   Ikawa M.   Okabe M.   Matsuda H.   Shirakura R.  

Transplant Immunology, Vol. 6, Iss. 2, 1998-06 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection

By Hammel J.M.   Elfeki S.K.   Kobayashi N.   Ito M.   Cai J.   Fearon D.T.   Graham F.L.   Fox I.J.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 939-939

Elsevier

Access to resources Recommend Favorite

Modulation of fluid-phase complement activation inhibits hyperacute rejection in a porcine-to-human xenograft model

By Fiane A.E.   Videm V.   Lambris J.D.   Geiran O.R.   Svennevig J.L.   Mollnes T.E.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 899-900

Elsevier

Access to resources Recommend Favorite

Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection

By Winkler M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3862-3864

Elsevier

Access to resources Recommend Favorite

Acute liver failure attenuates hyperacute xenograft rejection

By Stockmann H.B.A.C.   Hiemstra C.A.   Meijer R.   Marquet R.L.   IJzermans J.N.M.  

Transplantation Proceedings, Vol. 32, Iss. 5, 2000-08 ,pp. : 1114-1115

Elsevier

Access to resources Recommend Favorite